1. Signaling Pathways
  2. Cell Cycle/DNA Damage
  3. Checkpoint Kinase (Chk)
  4. BUBR1 Isoform

BUBR1

BUBR1 is an essential spindle assembly checkpoint protein that prevents premature anaphase onset and supports chromosome alignment and kinetochore-microtubule attachment[1]. Mechanistically, BUBR1 inhibits APC/C^Cdc20 through its N-terminal Cdc20-binding KEN-box region, allowing cyclin B accumulation before mitotic entry[2]. At kinetochores, BUBR1 links mitotic checkpoint signaling with chromosome-spindle attachment control and regulates CENP-A/Aurora kinase-associated attachment stability[3]. In human cells, BUBR1/BUB3 exists in functionally distinct kinetochore pools: a Bub1-dependent pool supports chromosome alignment, whereas KNL1-MELT binding strengthens checkpoint-complex incorporation[4]. Compared with Bub1, Bub1 is required for kinetochore localization of BUBR1, CENP-E, CENP-F, and Mad2, while BUBR1 is not required for kinetochore localization of Bub1 in human somatic cells[5]. In disease models, reduced BUBR1 causes progressive aneuploidy, senescence, infertility, and progeroid phenotypes in mice, whereas sustained high-level BUBR1 expression preserves genomic integrity and reduces tumorigenesis[6][7]. For experimental applications, bubristatin acts as a selective BUBR1 kinase antagonist and helps dissect BUBR1-CENP-E control of end-on microtubule capture[8].

BUBR1 Related Products (1):

Cat. No. Product Name Effect Purity
  • HY-13649
    Indibulin
    Activator 99.89%
    Indibulin (ZIO 301), an orally applicable inhibitor of tubulin assembly, shows potent anticancer activity with a minimal neurotoxicity. Indibulin reduces inter-kinetochoric tension, produces aberrant spindles, activates mitotic checkpoint proteins Mad2 and BubR1, and induces mitotic arrest and apoptosis.